PHARMATHENE, INC.

Company

Altimmune, Inc.

Filed

August 13, 2007

Accession Number

0000950135-07-005019

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →